194 related articles for article (PubMed ID: 28669723)
1. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
Cheon JH; Kim KS; Yadav DK; Kim M; Kim HS; Yoon S
Biochem Biophys Res Commun; 2017 Sep; 490(4):1176-1182. PubMed ID: 28669723
[TBL] [Abstract][Full Text] [Related]
2. P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression.
Cheon JH; Kim JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2017 Dec; 37(12):6761-6769. PubMed ID: 29187454
[TBL] [Abstract][Full Text] [Related]
3. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.
Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562984
[TBL] [Abstract][Full Text] [Related]
4. Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance.
Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
Anticancer Res; 2022 May; 42(5):2433-2442. PubMed ID: 35489775
[TBL] [Abstract][Full Text] [Related]
5. P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
Kim JY; Park Y; Lee BM; Kim HS; Yoon S
Anticancer Res; 2018 Oct; 38(10):5685-5692. PubMed ID: 30275188
[TBL] [Abstract][Full Text] [Related]
6. A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
Jiang C; Lee SH; Park JH; Lee JS; Park JW; Kim JR; Lee SH; Kim HS; Yoon S
Anticancer Res; 2021 Feb; 41(2):687-697. PubMed ID: 33517273
[TBL] [Abstract][Full Text] [Related]
7. Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
Kim JY; Son JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2018 Sep; 38(9):5149-5157. PubMed ID: 30194162
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp.
Kim JY; Kim HS; Yoon S
Anticancer Res; 2019 Jul; 39(7):3785-3793. PubMed ID: 31262905
[TBL] [Abstract][Full Text] [Related]
9. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
Kim JY; Park YJ; Lee BM; Yoon S
Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
[TBL] [Abstract][Full Text] [Related]
10. Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells.
Kim JY; Tae IH; Lee BM; Kim HS; Yoon S
Anticancer Res; 2018 Sep; 38(9):5101-5108. PubMed ID: 30194155
[TBL] [Abstract][Full Text] [Related]
11. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
12. Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
Kim JY; Kim KS; Kim IS; Yoon S
Anticancer Res; 2019 Jul; 39(7):3767-3775. PubMed ID: 31262903
[TBL] [Abstract][Full Text] [Related]
13. NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo.
Hua Y; Wang W; Zheng X; Yang L; Wu H; Hu Z; Li Y; Yue J; Jiang Z; Zhang X; Hou Q; Wu S
Drug Des Devel Ther; 2020; 14():745-755. PubMed ID: 32158193
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805.
Baffert F; Régnier CH; De Pover A; Pissot-Soldermann C; Tavares GA; Blasco F; Brueggen J; Chène P; Drueckes P; Erdmann D; Furet P; Gerspacher M; Lang M; Ledieu D; Nolan L; Ruetz S; Trappe J; Vangrevelinghe E; Wartmann M; Wyder L; Hofmann F; Radimerski T
Mol Cancer Ther; 2010 Jul; 9(7):1945-55. PubMed ID: 20587663
[TBL] [Abstract][Full Text] [Related]
15. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
16. Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition.
Choi AR; Jee Jo M; Jung MJ; Sik Kim H; Yoon S
Eur J Pharmacol; 2015 Oct; 764():63-69. PubMed ID: 26134503
[TBL] [Abstract][Full Text] [Related]
17. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
18. Sensitization Effects of Repurposed Blood Pressure-regulating Drugs on Drug-resistant Cancer Cells.
Jiang C; Zheng T; Park JH; Lee JS; Oh Y; Kundu A; Kim HS; Yoon S
Anticancer Res; 2021 Dec; 41(12):6179-6190. PubMed ID: 34848472
[TBL] [Abstract][Full Text] [Related]
19. Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
Park Y; Son JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2017 Aug; 37(8):4139-4146. PubMed ID: 28739698
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
Lee JS; Oh Y; Kim HS; Yoon S
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
